Cargando…
Downregulation of circulating exosomal miR-638 predicts poor prognosis in colon cancer patients
Exosome-encapsulated microRNAs have been recognized as novel and stable biomarkers for cancer. However, little is known about the role of exosomal microRNAs in colon cancer. In the present study, we investigated the expression of serous exosomal microRNA-638 (miR-638) and its prognostic effect in pa...
Autores principales: | Yan, Shushan, Dang, Guangwang, Zhang, Xiaoyu, Jin, Chengwen, Qin, Lang, Wang, Yugang, Shi, Min, Huang, Haijin, Duan, Quanhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641124/ https://www.ncbi.nlm.nih.gov/pubmed/29069781 http://dx.doi.org/10.18632/oncotarget.19689 |
Ejemplares similares
-
Downregulation of miR-638 promotes progression of breast cancer and is associated with prognosis of breast cancer patients
por: Li, Minghong, et al.
Publicado: (2018) -
Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells
por: Yokota, Yuki, et al.
Publicado: (2021) -
Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1
por: Yang, Jing, et al.
Publicado: (2020) -
Exosomal miR-638 Inhibits Hepatocellular Carcinoma Progression by Targeting SP1 [Retraction]
Publicado: (2021) -
Downregulation of serum exosomal miR‐320d predicts poor prognosis in hepatocellular carcinoma
por: Li, Wenxiao, et al.
Publicado: (2020)